We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

34 hedge funds and large institutions have $45.5M invested in ALPS Medical Breakthroughs ETF in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more call options, than puts

Call options by funds: $250K | Put options by funds: $132K

24% more capital invested

Capital invested by funds: $36.6M → $45.5M (+$8.91M)

4.28% more ownership

Funds ownership: 40.56% → 44.84% (+4.3%)

6% less funds holding

Funds holding: 36 → 34 (-2)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

62% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 13

Holders
34
Holders Change
-2
Holders Change %
-5.56%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
13
Closed
7
Calls
$250K
Puts
$132K
Net Calls
+$118K
Net Calls Change
-$94K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.33M
2
Wells Fargo
Wells Fargo
California
+$830K
3
Bank of America
Bank of America
North Carolina
+$759K
4
VF
Virtu Financial
New York
+$422K
5
GAM
Griffin Asset Management
New York
+$214K

Top Sellers

Rank Fund Capital Flow
1
SFS
Strategic Financial Services
New York
-$1.2M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$499K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$357K
4
NAM
NTV Asset Management
West Virginia
-$336K
5
Citadel Advisors
Citadel Advisors
Florida
-$265K
Name Holding Trade Value Shares
Change 		Change in
Stake
S
26
SignatureFD
Georgia
$6.59K – – –
ADL
27
Asset Dedication LLC
California
$6K – – –
FFA
28
Farther Finance Advisors
California
$4.22K – – –
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$3.35K +$2.69K +100 New
FCAS
30
First Command Advisory Services
Texas
$3.29K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$3.29K – – –
SL
32
Salomon & Ludwin
Virginia
$2.72K – – –
AFG
33
Albion Financial Group
Utah
$396 – – –
OP
34
ORG Partners
Indiana
$363 +$295 +11 New
RI
35
Ridgewood Investments
New Jersey
– -$9.69K -25,800 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$499K -18,574 Closed
Cambridge Investment Research Advisors
37
Cambridge Investment Research Advisors
Iowa
– -$243K -8,923 Closed
HWM
38
HighMark Wealth Management
Minnesota
– -$23.1K -850 Closed
VNA
39
Valley National Advisers
Pennsylvania
– -$4K -147 Closed
IA
40
IFP Advisors
Florida
– -$2.26K -83 Closed
HL
41
HeadInvest LLC
Maine
– -$105 -4 Closed
1
2

SBIO Hedge Fund Activity: Q4 2023 in Review

34 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2023, worth a combined $45.5M — up 24% from $36.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SBIO and 6 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 5 added.

The largest buyer was Morgan Stanley, adding an estimated $1.33M. The largest seller was Strategic Financial Services, cutting an estimated $1.2M.

  • 34 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2023, down from 36 in Q3 2023.
  • Funds reported $45.5M of ALPS Medical Breakthroughs ETF stock for Q4 2023, up 24% quarter-over-quarter.
  • 6 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2023 and 7 closed out, a net change of -1 holder.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q4 2023 was Morgan Stanley, an estimated $1.33M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q4 2023 was Strategic Financial Services, an estimated $1.2M sold.

Based on aggregated 13F filings for Q4 2023.